176 related articles for article (PubMed ID: 12827615)
1. Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas.
Frierson HF; Moskaluk CA; Powell SM; Zhang H; Cerilli LA; Stoler MH; Cathro H; Hampton GM
Hum Pathol; 2003 Jun; 34(6):605-9. PubMed ID: 12827615
[TBL] [Abstract][Full Text] [Related]
2. Application of mesothelin immunostaining in tumor diagnosis.
Ordóñez NG
Am J Surg Pathol; 2003 Nov; 27(11):1418-28. PubMed ID: 14576474
[TBL] [Abstract][Full Text] [Related]
3. Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types.
Lamberts LE; de Groot DJ; Bense RD; de Vries EG; Fehrmann RS
Oncotarget; 2015 Sep; 6(29):28164-72. PubMed ID: 26172299
[TBL] [Abstract][Full Text] [Related]
4. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
Ordóñez NG
Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
[TBL] [Abstract][Full Text] [Related]
5. Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways.
Cao D; Maitra A; Saavedra JA; Klimstra DS; Adsay NV; Hruban RH
Mod Pathol; 2005 Jun; 18(6):752-61. PubMed ID: 15696124
[TBL] [Abstract][Full Text] [Related]
6. Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors.
Weidemann S; Gagelmann P; Gorbokon N; Lennartz M; Menz A; Luebke AM; Kluth M; Hube-Magg C; Blessin NC; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Izbicki JR; Jansen K; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech RH; Dum D; Krech T; Marx AH; Simon R
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33917081
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of HE4 expression in normal and malignant human tissues.
Galgano MT; Hampton GM; Frierson HF
Mod Pathol; 2006 Jun; 19(6):847-53. PubMed ID: 16607372
[TBL] [Abstract][Full Text] [Related]
8. Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma.
Yen MJ; Hsu CY; Mao TL; Wu TC; Roden R; Wang TL; Shih IeM
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):827-31. PubMed ID: 16467095
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human mesothelin transcripts in ovarian and pancreatic cancer.
Muminova ZE; Strong TV; Shaw DR
BMC Cancer; 2004 May; 4():19. PubMed ID: 15140265
[TBL] [Abstract][Full Text] [Related]
10. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
Argani P; Iacobuzio-Donahue C; Ryu B; Rosty C; Goggins M; Wilentz RE; Murugesan SR; Leach SD; Jaffee E; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Clin Cancer Res; 2001 Dec; 7(12):3862-8. PubMed ID: 11751476
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing breast carcinoma from Müllerian serous carcinoma with mammaglobin and mesothelin.
Kanner WA; Galgano MT; Stoler MH; Mills SE; Atkins KA
Int J Gynecol Pathol; 2008 Oct; 27(4):491-5. PubMed ID: 18753974
[TBL] [Abstract][Full Text] [Related]
12. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.
Swierczynski SL; Maitra A; Abraham SC; Iacobuzio-Donahue CA; Ashfaq R; Cameron JL; Schulick RD; Yeo CJ; Rahman A; Hinkle DA; Hruban RH; Argani P
Hum Pathol; 2004 Mar; 35(3):357-66. PubMed ID: 15017593
[TBL] [Abstract][Full Text] [Related]
13. Gene expression patterns in ovarian carcinomas.
Schaner ME; Ross DT; Ciaravino G; Sorlie T; Troyanskaya O; Diehn M; Wang YC; Duran GE; Sikic TL; Caldeira S; Skomedal H; Tu IP; Hernandez-Boussard T; Johnson SW; O'Dwyer PJ; Fero MJ; Kristensen GB; Borresen-Dale AL; Hastie T; Tibshirani R; van de Rijn M; Teng NN; Longacre TA; Botstein D; Brown PO; Sikic BI
Mol Biol Cell; 2003 Nov; 14(11):4376-86. PubMed ID: 12960427
[TBL] [Abstract][Full Text] [Related]
14. Mesothelin (MSLN) promoter is hypomethylated in malignant mesothelioma, but its expression is not associated with methylation status of the promoter.
Tan K; Kajino K; Momose S; Masaoka A; Sasahara K; Shiomi K; Izumi H; Abe M; Ohtsuji N; Wang T; Hino O; Fujii H
Hum Pathol; 2010 Sep; 41(9):1330-8. PubMed ID: 20573372
[TBL] [Abstract][Full Text] [Related]
15. Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness.
Weidemann S; Perez D; Izbicki JR; Neipp M; Mofid H; Daniels T; Nahrstedt U; Jacobsen F; Bernreuther C; Simon R; Steurer S; Burandt E; Marx AH; Krech T; Clauditz TS; Jansen K
Cancer Invest; 2021 Oct; 39(9):711-720. PubMed ID: 34143695
[TBL] [Abstract][Full Text] [Related]
16. Expression of candidate tumor markers in ovarian carcinoma and benign ovary: evidence for a link between epithelial phenotype and neoplasia.
Drapkin R; Crum CP; Hecht JL
Hum Pathol; 2004 Aug; 35(8):1014-21. PubMed ID: 15297969
[TBL] [Abstract][Full Text] [Related]
17. Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma.
Inami K; Kajino K; Abe M; Hagiwara Y; Maeda M; Suyama M; Watanabe S; Hino O
Oncol Rep; 2008 Dec; 20(6):1375-80. PubMed ID: 19020717
[TBL] [Abstract][Full Text] [Related]
18. Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy.
Alvarez H; Rojas PL; Yong KT; Ding H; Xu G; Prasad PN; Wang J; Canto M; Eshleman JR; Montgomery EA; Maitra A
Nanomedicine; 2008 Dec; 4(4):295-301. PubMed ID: 18691948
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive analysis of PAX8 expression in human epithelial tumors.
Laury AR; Perets R; Piao H; Krane JF; Barletta JA; French C; Chirieac LR; Lis R; Loda M; Hornick JL; Drapkin R; Hirsch MS
Am J Surg Pathol; 2011 Jun; 35(6):816-26. PubMed ID: 21552115
[TBL] [Abstract][Full Text] [Related]
20. Loss of SMAD4 protein expression in gastrointestinal and extra-gastrointestinal carcinomas.
Ritterhouse LL; Wu EY; Kim WG; Dillon DA; Hirsch MS; Sholl LM; Agoston AT; Setia N; Lauwers GY; Park DY; Srivastava A; Doyle LA
Histopathology; 2019 Oct; 75(4):546-551. PubMed ID: 31054158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
